about
Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs.Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4Diabetes-induced mechanophysiological changes in the small intestine and colon.The next generation of artificial pancreas control algorithms.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gut peptides in the treatment of diabetes mellitus.
@ast
Gut peptides in the treatment of diabetes mellitus.
@en
type
label
Gut peptides in the treatment of diabetes mellitus.
@ast
Gut peptides in the treatment of diabetes mellitus.
@en
prefLabel
Gut peptides in the treatment of diabetes mellitus.
@ast
Gut peptides in the treatment of diabetes mellitus.
@en
P2860
P1476
Gut peptides in the treatment of diabetes mellitus.
@en
P2093
David A D'Alessio
Torsten P Vahl
P2860
P304
P356
10.1517/13543784.13.3.177
P407
P577
2004-03-01T00:00:00Z